ALTEOGEN INC.
Patent Owner
Stats
- 6 US PATENTS IN FORCE
- 1 US APPLICATIONS PENDING
- Feb 27, 2018 most recent publication
Details
- 6 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 85 Total Citation Count
- Mar 12, 2003 Earliest Filing
- 1 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0119,903 MODIFIED ANTIBODY IN WHICH MOTIF COMPRISING CYSTEINE RESIDUE IS BOUND, MODIFIED ANTIBODY-DRUG CONJUGATE COMPRISING THE MODIFIED ANTIBODY, AND PRODUCTION METHOD FOR SAMEDec 29, 16May 04, 17[A61K, C07K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9821059 Composition for stabilizing protein and pharmaceutical formulation comprising the sameOct 15, 15Nov 21, 17[A61K, C07K]
9814782 Modified antibody in which motif comprising cysteine residue is bound, modified antibody-drug conjugate comprising the modified antibody, and production method for sameFeb 22, 13Nov 14, 17[A61K, C07K]
9474803 Composition for stabilizing fusion protein in which protein and FC domain are fusedOct 23, 13Oct 25, 16[C01C, C09K, A61K, C07K]
9051395 Alpha-1 antitrypsin variant, preparation method thereof and use thereofAug 13, 12Jun 09, 15[A61K, C07K]
9012606 In vivo half life increased fusion protein or peptide maintained by sustained in vivo release, and method for increasng in vivo half-life using sameApr 22, 10Apr 21, 15[C07K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
7416839 "Prionins", highly specific markers for noninvasive presymptomatic detection of TSE diseases, and targets for therapeutic reagents to prevent and control TSE diseases in animals and humansExpiredMar 12, 03Aug 26, 08[G01N]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.